Cardiovascular disease in HIV-positive patients

This publication has 99 references indexed in Scilit:

• Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy
  AIDS, 2003
• Clinical Features and Metabolic Derangements in Acquired Generalized Lipodystrophy
  Medicine, 2003
• Longitudinal evolution of HIV‐1‐associated lipodystrophy is correlated to serum cortisol:DHEA ratio and IFN‐α
  European Journal of Clinical Investigation, 2002
• Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression
  Clinical Infectious Diseases, 2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy
  Clinical Infectious Diseases, 2001
• Impact of Switching from Human Immunodeficiency Virus Type 1 Protease Inhibitors to Efavirenz in Successfully Treated Adults with Lipodystrophy
  Clinical Infectious Diseases, 2000
• Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
  New England Journal of Medicine, 2000
• An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular Walls
  Hormone and Metabolic Research, 2000
• Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris: Results from the APSIS study
  Atherosclerosis, 2000